185 related articles for article (PubMed ID: 34189870)
1. Impact of beta-blocker use on the long-term outcomes of heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Tay WT; Teng TK; Asai K; Noda T; Kusano K; Suzuki A; Hagiwara N; Hisatake S; Ikeda T; Yasuoka R; Kurita T; Shimizu W;
ESC Heart Fail; 2021 Oct; 8(5):3791-3799. PubMed ID: 34189870
[TBL] [Abstract][Full Text] [Related]
2. Chronic obstructive pulmonary disease and β-blocker treatment in Asian patients with heart failure.
Kubota Y; Tay WT; Asai K; Murai K; Nakajima I; Hagiwara N; Ikeda T; Kurita T; Teng TK; Anand I; Lam CSP; Shimizu W;
ESC Heart Fail; 2018 Apr; 5(2):297-305. PubMed ID: 29055972
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF.
Ehteshami-Afshar S; Mooney L; Dewan P; Desai AS; Lang NN; Lefkowitz MP; Petrie MC; Rizkala AR; Rouleau JL; Solomon SD; Swedberg K; Shi VC; Zile MR; Packer M; McMurray JJV; Jhund PS; Hawkins NM
J Am Heart Assoc; 2021 Feb; 10(4):e019238. PubMed ID: 33522249
[TBL] [Abstract][Full Text] [Related]
4. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
5. Effects of dapagliflozin in heart failure with reduced ejection fraction and chronic obstructive pulmonary disease: an analysis of DAPA-HF.
Dewan P; Docherty KF; Bengtsson O; de Boer RA; Desai AS; Drozdz J; Hawkins NM; Inzucchi SE; Kitakaze M; Køber L; Kosiborod MN; Langkilde AM; Lindholm D; Martinez FA; Merkely B; Petrie MC; Ponikowski P; Sabatine MS; Schou M; Sjöstrand M; Solomon SD; Verma S; Jhund PS; McMurray JJV
Eur J Heart Fail; 2021 Apr; 23(4):632-643. PubMed ID: 33368858
[TBL] [Abstract][Full Text] [Related]
6. Association of beta-blocker treatment with mortality following myocardial infarction in patients with chronic obstructive pulmonary disease and heart failure or left ventricular dysfunction: a propensity matched-cohort analysis from the High-Risk Myocardial Infarction Database Initiative.
Coiro S; Girerd N; Rossignol P; Ferreira JP; Maggioni A; Pitt B; Tritto I; Ambrosio G; Dickstein K; Zannad F
Eur J Heart Fail; 2017 Feb; 19(2):271-279. PubMed ID: 27774703
[TBL] [Abstract][Full Text] [Related]
7. Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.
Jaiswal A; Chichra A; Nguyen VQ; Gadiraju TV; Le Jemtel TH
Curr Heart Fail Rep; 2016 Feb; 13(1):30-6. PubMed ID: 26780914
[TBL] [Abstract][Full Text] [Related]
8. Effects of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction patients with chronic obstructive pulmonary disease in EMPHASIS-HF and RALES.
Yeoh SE; Dewan P; Serenelli M; Ferreira JP; Pitt B; Swedberg K; van Veldhuisen DJ; Zannad F; Jhund PS; McMurray JJV
Eur J Heart Fail; 2022 Mar; 24(3):529-538. PubMed ID: 34536265
[TBL] [Abstract][Full Text] [Related]
9. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
10. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
11. Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
Lin CH; Yeh JK; Lin TY; Lo YL; Chang BJ; Ju JS; Chiu TH; Tung PH; Huang YJ; Lin SM
BMC Pulm Med; 2023 Feb; 23(1):67. PubMed ID: 36805703
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
[TBL] [Abstract][Full Text] [Related]
13. Underuse of β-blockers in heart failure and chronic obstructive pulmonary disease.
Lipworth B; Skinner D; Devereux G; Thomas V; Ling Zhi Jie J; Martin J; Carter V; Price DB
Heart; 2016 Dec; 102(23):1909-1914. PubMed ID: 27380949
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.
Ouwerkerk W; Teng TK; Tromp J; Tay WT; Cleland JG; van Veldhuisen DJ; Dickstein K; Ng LL; Lang CC; Anker SD; Zannad F; Hung CL; Sawhney JPS; Naik A; Shimizu W; Hagiwara N; Wander GS; Anand I; Richards AM; Voors AA; Lam CSP
Eur J Heart Fail; 2020 Aug; 22(8):1472-1482. PubMed ID: 32583922
[TBL] [Abstract][Full Text] [Related]
15. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry.
Canepa M; Straburzynska-Migaj E; Drozdz J; Fernandez-Vivancos C; Pinilla JMG; Nyolczas N; Temporelli PL; Mebazaa A; Lainscak M; Laroche C; Maggioni AP; Piepoli MF; Coats AJS; Ferrari R; Tavazzi L;
Eur J Heart Fail; 2018 Jan; 20(1):100-110. PubMed ID: 28949063
[TBL] [Abstract][Full Text] [Related]
16. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics, response to exercise training, and outcomes in patients with heart failure and chronic obstructive pulmonary disease: findings from Heart Failure and A Controlled Trial Investigating Outcomes of Exercise TraiNing (HF-ACTION).
Mentz RJ; Schulte PJ; Fleg JL; Fiuzat M; Kraus WE; Piña IL; Keteyian SJ; Kitzman DW; Whellan DJ; Ellis SJ; O'Connor CM
Am Heart J; 2013 Feb; 165(2):193-9. PubMed ID: 23351822
[TBL] [Abstract][Full Text] [Related]
18. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure.
Rusinaru D; Saaidi I; Godard S; Mahjoub H; Battle C; Tribouilloy C
Am J Cardiol; 2008 Feb; 101(3):353-8. PubMed ID: 18237599
[TBL] [Abstract][Full Text] [Related]
19. Relationship between heart failure, concurrent chronic obstructive pulmonary disease and beta-blocker use: a Danish nationwide cohort study.
Sessa M; Mascolo A; Mortensen RN; Andersen MP; Rosano GMC; Capuano A; Rossi F; Gislason G; Enghusen-Poulsen H; Torp-Pedersen C
Eur J Heart Fail; 2018 Mar; 20(3):548-556. PubMed ID: 29159953
[TBL] [Abstract][Full Text] [Related]
20. The clinical characteristics and outcomes of heart failure patient with chronic obstructive pulmonary disease from the Japanese community-based registry.
Takabayashi K; Terasaki Y; Okuda M; Nakajima O; Koito H; Kitamura T; Kitaguchi S; Nohara R
Heart Vessels; 2021 Feb; 36(2):223-234. PubMed ID: 32770265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
